āagman

Not investment advice. Data and computed figures, for information only.

Suven Life Sciences Ltd

NSE: SUVEN
₹300.25
+₹14.80 (+5.18%)
NSE · 15 Oct 2026, close
As of 31 Mar 2026
Market Cap
₹7,989 Cr
CMP
₹300.25
52-wk High / Low
₹403 / 124
P/B
12.6
Book Value
₹22.4
Div Yield
0.00%
ROCE
−80.0%
ROE
−81.5%
Face Value
₹1
D/E
0.03

Price+43.4% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 13 quarters of filings. Not reported by the company.
As of 15 Oct 2026
Piotroski F-Score
1
/ 9
1 of 9 F-score tests passed
ROIC
−47.7%
vs 11.2% sector median
Cash flow to profit
0.56
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−75,000
bps OPM YoY
Operating margin vs the same quarter last year
ROE stability
48.2
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom −4.68FII −0.43DII −1.89
Latest quarter vs the previous one
Cash-accrual divergence
6.3%
of assets
Low = accruals track cash flow
Strengths
+Borrowings are down 79.5% since FY2016 (83 to 17)
+Price trades above its 200-day moving average (1.2x)
Watch-outs
−Latest ROCE of -80% trails the sector median of 17%
−Annualised volatility of 57.0% is in the high band (≥45%)
−Promoter holding fell by 4.1pp over the last year
−Piotroski F-Score of 1/9 is in the weak band (≤3)

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales4322132121324
Expenses3227493332554145538110652136
Operating Profit−28−24−46−30−31−52−39−44−51−80−103−51−132
OPM %−700.0%−800.0%−2,300.0%−1,500.0%−3,100.0%−1,733.3%−1,950.0%−4,400.0%−2,550.0%−8,000.0%−3,433.3%−2,550.0%−3,300.0%
Other Income61364442114378
Interest0000000000000
Depreciation2222112111122
Profit before tax−24−13−42−28−28−50−39−44−52−77−102−46−128
Net Profit−24−13−42−27−28−50−39−44−52−77−102−46−128
EPS (₹)−1.10−0.58−1.91−1.22−1.29−2.28−1.79−2.01−2.36−3.40−4.48−1.73−4.83

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5214995436252861313121412779
Expenses36139841442730012893134139140172291375
Operating Profit159102129198−14−116−80−122−126−128−166−284−366
OPM %30.5%20.4%23.8%31.7%−4.9%−892.3%−615.4%−1,016.7%−900.0%−1,066.7%−2,371.4%−4,057.1%−4,066.7%
Other Income91921232714851429111421
Interest5665211100001
Depreciation121821211144476666
Profit before tax152981231960−106−77−122−118−106−161−276−352
Net Profit1097287124−24−94−72−122−118−105−161−276−352
EPS (₹)5.703.764.576.48−1.25−4.94−3.78−5.59−5.42−4.82−7.37−10.48−14.44

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital131313131313131522222226—
Reserves547583654755226131958235424888565—
Borrowings109837134365321017—
Other Liabilities1057478118623316912142516—
Total Liabilities773751816919303182128108389285135624—
Fixed Assets1723053063082225213837286073—
CWIP1077102500540004—
Investments003012792230045467622181—
Other Assets494439199308581571032230518153367—
Total Assets773751816919303182128108389285135624—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity1436810970−53−135−96−128−116−115−155−300
Cash from Investing Activity−110−39−311−13014656−22−24894155−462
Cash from Financing Activity179−68−30−525335146396−1−1757
Net Cash Flow212−39−23217−1814−5−432−22−1−5

Ratios

As of 31 Mar 2026
12 periods
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—13.015.024.0−4.0−54.0−58.0−118.0−53.0−36.0−87.0−80.0
ROE %———————————−81.5
EPS (₹)5.703.764.576.48−1.25−4.94−3.78−5.59−5.42−4.82−7.37−10.48
Book Value (₹)———————————22.4
Face Value (₹)———————————1
P/E————————————
Div Yield %———————————0.00
NPM %20.613.915.419.1−7.7−348.1−342.9−717.6−421.4−256.1−894.4−1,314.3
OPM %31.020.024.032.0−5.0−917.0−593.0—−929.0———
D/E0.190.140.110.040.010.040.050.030.010.000.000.03
P/B———————————12.6

Growth

As of 11 Oct 2026
Compounded sales growth
10 years−35.0%
5 years−12.0%
3 years−19.0%
TTM+17.0%
Compounded profit growth
TTM−91.0%
Stock price CAGR
10 years+37.0%
5 years+22.0%
3 years+58.0%
Last year+35.0%
Return on equity
10 years−24.0%
5 years−68.0%
3 years−66.0%
Last year−82.0%

Shareholding pattern

As of 30 Jun 2026
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters60.00%60.00%60.00%60.00%60.00%64.98%69.56%69.56%70.26%70.15%65.47%
FIIs1.97%2.50%5.67%3.95%0.48%0.45%0.51%0.46%0.25%0.91%0.48%
DIIs5.27%4.85%2.48%0.86%0.66%0.46%0.11%1.05%0.01%4.62%2.73%
Government———————————
Public32.76%32.65%31.85%35.19%38.86%34.11%29.80%28.91%29.47%24.32%31.32%
No. of shareholders67,59464,10264,28169,63877,65081,03978,63468,95964,60363,91566,647
Change since Dec 2023 (pp)
Promoters +5.47FIIs −1.49DIIs −2.54Public −1.44

Documents

As of 11 Oct 2026

Corporate actions

As of 17 Oct 2022
17 Oct 2022RIGHTSRights 1:2 @ Premium Rs 54/-—
21 Jan 2020DEMERGER Demerger—
14 Feb 2019DIVIDEND Interim Dividend - Rs 1.50 Per Share—
6 Feb 2018DIVIDEND Interim Dividend - Rs 1.50 Per Share (Purpose Revised)—
8 Feb 2017DIVIDEND Interim Dividend Re 1 Per Share—
14 Mar 2016DIVIDEND Interim Dividend - Re 1/- Per Share / Special Dividend - Re 1/- Per Share (Purpose Revised)—
23 Jul 2015DIVIDENDAnnual General Meeting/Dividend - Re 0.60/- Per Share—
24 Jul 2014DIVIDENDAnnual General Meeting /Final Dividend - Re 0.50/- Per Share + Special Dividend - Rs 2/- Per Share—
1 Aug 2013DIVIDENDAnnual General Meeting / Dividend - Re.0.30/- Per Equity Share—
17 Sep 2012DIVIDENDAnnual General Meeting And Dividend Re.0.30 Per Share—
1 Aug 2011DIVIDENDAnnual General Meeting And Dividend Re.0.25 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman